Source: Fox News
Summary
A new study from the University of California San Diego found that a blood test could potentially determine a woman’s dementia risk up to 25 years before symptoms appear. The study analyzed blood samples from 2,766 women aged 65-79 and found that a specific biomarker protein, phosphorylated tau 217 (p-tau217), was strongly linked to future dementia risk. Women with higher levels of p-tau217 were more likely to develop dementia. The study’s findings suggest that a simple blood test could help identify individuals at higher risk for dementia long before symptoms begin.
Our Reading
The advice sounds familiar.
This guidance has been heard before. The concept of a blood test predicting dementia risk is not new, but the study’s findings suggest a potential breakthrough in early detection. The study’s lead author, Aladdin H. Shadyab, notes that the blood biomarker p-tau217 could help identify individuals at higher risk for dementia long before symptoms begin. However, more research is needed before this approach can be considered for clinical use.
The recommendation enters another phase. The study’s findings suggest that p-tau217 could be a useful tool for identifying individuals at higher risk for dementia, but it is not a guarantee. The study’s authors note that more research is needed to fully understand the relationship between p-tau217 and dementia risk.
It’s a familiar pattern: a promising new study, followed by cautious language and calls for more research. The study’s findings are intriguing, but it’s unclear how they will translate to real-world applications.
Author: Evan Null
